Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Little sedi action.

<< Previous

Bullboard Posts

Next >>

Comment by westcoast1000on Feb 27, 2023 9:23pm

136 Views

Post# 35308586

RE:RE:RE:RE:RE:RE:RE:RE:Little sedi action.

I see. You meant you suppose Pfizer is doing that, which is of course reasonable.

I can certainly wait to get out of this investment if it is good.

And we will not know enough to get out of it if it is bad until the final curtain.

Nevertheless, at the risk of repeating myself several times, the results of last year are very strong. That is what matters. Many different companies could buy us based on those results.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals